Exosome: A Novel Mediator in Drug Resistance of Cancer Cells

References

• Torre LA , BrayF , SiegelRL , FerlayJ , Lortet-TieulentJ , JemalA . Global cancer statistics, 2012 . CA Cancer J. Clin.65 ( 2 ), 87 – 108 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chen WX , LiuXM , LvMMet al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs . PLoS ONE9 ( 4 ), e95240 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hewson C , MorrisKV . Form and function of exosome-associated long non-coding RNAs in cancer . Curr. Top. Microbiol. Immunol.394 , 41 – 56 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Valadi H , EkstromK , BossiosA , SjostrandM , LeeJJ , LotvallJO . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells . Nat. Cell Biol.9 ( 6 ), 654 – 659 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Thery C , RegnaultA , GarinJet al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73 . J. Cell Biol.147 ( 3 ), 599 – 610 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Raposo G , NijmanHW , StoorvogelWet al. B lymphocytes secrete antigen-presenting vesicles . J. Exp. Med.183 ( 3 ), 1161 – 1172 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Blanchard N , LankarD , FaureFet al. CR activation of human T cells induces the production of exosomes bearing the TCR/CD3/ζ complex . J. Immunol.168 ( 7 ), 3235 – 3241 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Raposo G , TenzaD , MecheriS , PeronetR , BonnerotC , DesaymardC . Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation . Mol. Biol. Cell8 ( 12 ), 2631 – 2645 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Van Niel G , RaposoG , CandalhCet al. Intestinal epithelial cells secrete exosome-like vesicles . Gastroenterology121 ( 2 ), 337 – 349 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Mears R , CravenRA , HanrahanSet al. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry . Proteomics4 ( 12 ), 4019 – 4031 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Chiba M , KimuraM , AsariS . Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines . Oncol. Rep.28 ( 5 ), 1551 – 1558 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang Z , ChenJQ , LiuJL , TianL . Exosomes in tumor microenvironment: novel transporters and biomarkers . J. Transl. Med.14 ( 1 ), 297 ( 2016 ).
   PubMedGoogle Scholar
• Meads MB , GatenbyRA , DaltonWS . Environment-mediated drug resistance: a major contributor to minimal residual disease . Nat. Rev. Cancer9 ( 9 ), 665 – 674 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hu Y , YanC , MuLet al. Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer . PLoS ONE10 ( 5 ), e0125625 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Khalyfa A , AlmendrosI , Gileles-HillelAet al. Circulating exosomes potentiate tumor malignant properties in a mouse model of chronic sleep fragmentation . Oncotarget7 ( 34 ), 54676 – 54690 ( 2016 ).
   PubMedGoogle Scholar
• Skog J , WurdingerT , Van RijnSet al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers . Nat. Cell Biol.10 ( 12 ), 1470 – 1476 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Liu CM , HsiehCL , ShenCN , LinCC , ShigemuraK , SungSY . Exosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression . Int. J. Urol.23 ( 9 ), 734 – 744 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Yu DD , WuY , ShenHYet al. Exosomes in development, metastasis and drug resistance of breast cancer . Cancer Sci.106 ( 8 ), 959 – 964 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Qian Z , ShenQ , YangX , QiuY , ZhangW . The role of extracellular vesicles: an epigenetic view of the cancer microenvironment . BioMed Res. Int. 2015 , 1 – 8 ( 2015 ).
   Web of Science ®Google Scholar
• Singh R , PochampallyR , WatabeK , LuZ , MoYY . Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer . Mol. Cancer13 , 256 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhou W , FongMY , MinYet al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis . Cancer Cell25 ( 4 ), 501 – 515 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhang HD , JiangLH , SunDW , LiJ , TangJH . MiR-139-5p: promising biomarker for cancer . Tumour Biol.36 ( 3 ), 1355 – 1365 ( 2015 ).
   PubMedGoogle Scholar
• Chan LS , YuePY , WongYY , WongRN . MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2 . Biochem. Pharmacol.86 ( 3 ), 392 – 400 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jia Y , ChenY , WangQet al. Exosome: emerging biomarker in breast cancer . Oncotarget8 ( 25 ), 41717 – 41733 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Suchorska WM , LachMS . The role of exosomes in tumor progression and metastasis (review) . Oncol. Rep.35 ( 3 ), 1237 – 1244 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Luga V , ZhangL , Viloria-PetitAMet al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration . Cell151 ( 7 ), 1542 – 1556 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lin R , WangS , ZhaoRC . Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model . Mol. Cell. Biochem.383 ( 1–2 ), 13 – 20 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Azmi AS , BaoB , SarkarFH . Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review . Cancer Metastasis Rev.32 ( 3-4 ), 623 – 642 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yu DD , WuY , ZhangXHet al. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222 . Tumour Biol.37 ( 3 ), 3227 – 3235 ( 2016 ).
   PubMedGoogle Scholar
• Pink RC , SamuelP , MassaD , CaleyDP , BrooksSA , CarterDR . The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells . Gynecol. Oncol.137 ( 1 ), 143 – 151 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lou G , SongX , YangFet al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma . J. Hematol. Oncol.8 , 122 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pan Jun , DingM , XuKai , YangChunhua , MaoLi-Jun . Exosomes in diagnosis and therapy of prostate cancer . Oncotarget8 ( 57 ), 97693 – 97700 ( 2017 ).
   PubMedGoogle Scholar
• Patel GK , KhanMA , BhardwajAet al. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK . Br. J. Cancer116 ( 5 ), 609 – 619 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Lobb RJ , Van AmerongenR , WiegmansA , HamS , LarsenJE , MollerA . Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance . Int. J. Cancer141 ( 3 ), 614 – 620 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Ji R , ZhangB , ZhangXet al. Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer . Cell Cycle14 ( 15 ), 2473 – 2483 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tanday S . Global cancer cases on the rise . Lancet Oncol.16 ( 7 ), e317 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD , JemalA . Cancer statistics, 2016 . CA Cancer J. Clin.66 ( 1 ), 7 – 30 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Santos JC , RibeiroML , SarianLO , OrtegaMM , DerchainSF . Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation . Am. J. Cancer Res.6 ( 10 ), 2129 – 2139 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Sun T , YangM , KantoffP , LeeGS . Role of microRNA-221/-222 in cancer development and progression . Cell Cycle8 ( 15 ), 2315 – 2316 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bazot Q , PaschosK , SkalskaL , KalchschmidtJS , ParkerGA , AlldayMJ . Epstein–Barr virus proteins EBNA3A and EBNA3C together induce expression of the oncogenic microRNA cluster miR-221/miR-222 and ablate expression of its target p57KIP2 . PLoS Pathogens11 ( 7 ), e1005031 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pallante P , VisoneR , FerracinMet al. MicroRNA deregulation in human thyroid papillary carcinomas . Endocr. Relat. Cancer13 ( 2 ), 497 – 508 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Ciafre SA , GalardiS , MangiolaAet al. Extensive modulation of a set of microRNAs in primary glioblastoma . Biochem. Biophys. Res. Commun.334 ( 4 ), 1351 – 1358 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Galardi S , MercatelliN , GiordaEet al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1 . J. Biol. Chem.282 ( 32 ), 23716 – 23724 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Galardi S , MercatelliN , FaraceMG , CiafreSA . NF-κB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells . Nucleic Acids Res.39 ( 9 ), 3892 – 3902 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lee EJ , GusevY , JiangJet al. Expression profiling identifies microRNA signature in pancreatic cancer . Int. J. Cancer120 ( 5 ), 1046 – 1054 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Yang X , YangY , GanRet al. Down-regulation of mir-221 and mir-222 restrain prostate cancer cell proliferation and migration that is partly mediated by activation of SIRT1 . PLoS ONE9 ( 6 ), e98833 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yang Y , ZhaoX , LiHX . MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells . Eur. Rev. Med. Pharmacol. Sci.20 ( 8 ), 1509 – 1515 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ning T , ZhangH , WangXet al. miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer . Tumour Biol.39 ( 6 ), 1010428317701636 ( 2017 ).
   Google Scholar
• Wang DD , YangSJ , ChenXet al. miR-222 induces adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway . Tumour Biol.37 ( 11 ), 15315 – 15324 ( 2016 ).
   PubMedGoogle Scholar
• Shen H , WangD , LiLet al. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway . Gene596 , 110 – 118 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Sharrard RM , MaitlandNJ . Alternative splicing of the human PTEN/MMAC1/TEP1 gene . Biochimica Biophysica Acta1494 ( 3 ), 282 – 285 ( 2000 ).
   PubMedGoogle Scholar
• Maehama T , DixonJE . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate . J. Biol. Chem.273 ( 22 ), 13375 – 13378 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Sarbassov DD , AliSM , SenguptaSet al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB . Mol. Cell22 ( 2 ), 159 – 168 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Zhang L , DongY , ZhuNet al. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer . Mol. Cancer13 , 124 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kousteni S . FoxO1: a molecule for all seasons . J. Bone Miner. Res.26 ( 5 ), 912 – 917 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wei Y , LaiX , YuSet al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells . Breast Cancer Res. Treat.147 ( 2 ), 423 – 431 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhang HD , JiangLH , SunDW , LiJ , JiZL . The role of miR-130a in cancer . Breast Cancer24 ( 4 ), 521 – 527 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Lv MM , ZhuXY , ChenWXet al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein . Tumour Biol.35 ( 11 ), 10773 – 10779 ( 2014 ).
   PubMedGoogle Scholar
• Ning K , WangT , SunXet al. UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer . J. Surg. Oncol.115 ( 8 ), 932 – 940 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Wang W , ZouL , ZhouDet al. Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway . Mol. Carcinog.55 ( 9 ), 1329 – 1342 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Mao Y , ZhangY , QuQet al. Cancer-associated fibroblasts induce trastuzumab resistance in HER2 positive breast cancer cells . Mol. Biosystems11 ( 4 ), 1029 – 1040 ( 2015 ).
   PubMedGoogle Scholar
• Ciravolo V , HuberV , GhediniGCet al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy . J. Cell. Physiol.227 ( 2 ), 658 – 667 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Boelens Mirjam C , Wu TonyJ , Nabet BarzinYet al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways . Cell159 ( 3 ), 499 – 513 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ramalho JS , TolmachovaT , HumeANet al. Chromosomal mapping, gene structure and characterization of the human and murine RAB27B gene . BMC Genet.2 , 2 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Fornari F , GramantieriL , GiovanniniCet al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells . Cancer Res.69 ( 14 ), 5761 – 5767 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bai S , NasserMW , WangBet al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib . J. Biol. Chem.284 ( 46 ), 32015 – 32027 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Takahashi K , YanIK , KogureT , HagaH , PatelT . Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer . FEBS Open Bio.4 , 458 – 467 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kinugasa Y , MatsuiT , TakakuraN . CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment . Stem Cells32 ( 1 ), 145 – 156 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Nabavi N , SaidyNRN , VenalainenEet al. miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer . Sci. Rep.7 ( 1 ), 4079 ( 2017 ).
   PubMedGoogle Scholar
• Qin X , YuS , ZhouLet al. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner . Int. J. Nanomedicine12 , 3721 – 3733 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Karihtala P , AuvinenP , KauppilaS , HaapasaariKM , Jukkola-VuorinenA , SoiniY . Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype . Breast Cancer Res. Treat.138 ( 1 ), 81 – 90 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Corcoran C , RaniS , O’DriscollL . miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression . Prostate74 ( 13 ), 1320 – 1334 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Corcoran C , RaniS , O’BrienKet al. Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes . PLoS ONE7 ( 12 ), e50999 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Crow J , AtayS , BanskotaS , ArtaleB , SchmittS , GodwinAK . Exosomes as mediators of platinum resistance in ovarian cancer . Oncotarget8 ( 7 ), 11917 – 11936 ( 2017 ).
   PubMedGoogle Scholar
• Qu L , DingJ , ChenCet al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA . Cancer Cell29 ( 5 ), 653 – 668 ( 2016 ).
   PubMed Web of Science ®Google Scholar